[go: up one dir, main page]

ZA200703827B - New pyridothlenopyrimidine derivates - Google Patents

New pyridothlenopyrimidine derivates

Info

Publication number
ZA200703827B
ZA200703827B ZA200703827A ZA200703827A ZA200703827B ZA 200703827 B ZA200703827 B ZA 200703827B ZA 200703827 A ZA200703827 A ZA 200703827A ZA 200703827 A ZA200703827 A ZA 200703827A ZA 200703827 B ZA200703827 B ZA 200703827B
Authority
ZA
South Africa
Prior art keywords
pyridothlenopyrimidine
derivates
new
pyridothlenopyrimidine derivates
new pyridothlenopyrimidine
Prior art date
Application number
ZA200703827A
Other languages
English (en)
Inventor
Page Santacana Lluis Miquel
Taltavull Moll Joan
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of ZA200703827B publication Critical patent/ZA200703827B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200703827A 2004-11-30 2007-05-11 New pyridothlenopyrimidine derivates ZA200703827B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402876A ES2259891B1 (es) 2004-11-30 2004-11-30 Nuevos derivados de piridotienopirimidina.

Publications (1)

Publication Number Publication Date
ZA200703827B true ZA200703827B (en) 2008-08-27

Family

ID=35064879

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703827A ZA200703827B (en) 2004-11-30 2007-05-11 New pyridothlenopyrimidine derivates

Country Status (21)

Country Link
US (1) US20090029955A1 (xx)
EP (1) EP1819710B1 (xx)
JP (1) JP2008521855A (xx)
KR (1) KR20070086869A (xx)
CN (1) CN101068816A (xx)
AR (1) AR051686A1 (xx)
AT (1) ATE425167T1 (xx)
AU (1) AU2005311423A1 (xx)
BR (1) BRPI0518094A (xx)
CA (1) CA2588741A1 (xx)
DE (1) DE602005013278D1 (xx)
ES (2) ES2259891B1 (xx)
IL (1) IL183142A0 (xx)
MX (1) MX2007006173A (xx)
NO (1) NO20073283L (xx)
PE (1) PE20061078A1 (xx)
RU (1) RU2007124326A (xx)
TW (1) TW200635932A (xx)
UY (1) UY29239A1 (xx)
WO (1) WO2006058724A1 (xx)
ZA (1) ZA200703827B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
ES2281251B1 (es) * 2005-07-27 2008-08-16 Laboratorios Almirall S.A. Nuevos derivados de pirido (3',2':4,5) furo (3,2-d) pirimidina.
MX2008004024A (es) * 2005-09-23 2009-02-27 Schering Corp Antagonistas de receptor de glutamato metabotropico-1 tetraciclicos fusionados como agentes terapeuticos.
BR112012026157A2 (pt) * 2010-04-14 2015-09-08 Bayer Cropscience Ag processo para preparar ditiina-tetracarboximidas.
BR112018003417B1 (pt) 2016-06-22 2023-10-24 Vanderbilt University Composto modulador alostérico positivo do receptor muscarínico de acetilcolina m4 e composição farmacêutica que o compreende
ES2892956T3 (es) 2016-11-07 2022-02-07 Univ Vanderbilt Moduladores alostéricos positivos del receptor muscarínico de acetilcolina M4
EP3558309B1 (en) 2016-11-07 2023-07-26 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
MA46722A (fr) 2016-11-07 2019-09-11 Univ Vanderbilt Modulateurs allostériques positifs du récepteur muscarinique à l'acétylcholine m4
TW201930311A (zh) 2017-12-05 2019-08-01 泛德比爾特大學 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑
CN111406058A (zh) 2017-12-05 2020-07-10 范德比尔特大学 毒蕈碱型乙酰胆碱受体m4的正向别构调节剂
WO2021095032A1 (en) * 2019-11-13 2021-05-20 Metabomed Ltd Glucose uptake inhibitors and uses thereof
CN115684415B (zh) * 2022-11-02 2024-09-10 山东华泰新材料技术研发有限公司 一种高效液相色谱测定5,6-二氢环戊并[b]噻吩-4-酮含量的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) * 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
WO2000059912A1 (en) * 1999-03-30 2000-10-12 Nippon Soda Co., Ltd. Thienopyrimidine compounds and salts thereof and process for the preparation of the same

Also Published As

Publication number Publication date
UY29239A1 (es) 2006-02-24
ES2321966T3 (es) 2009-06-15
DE602005013278D1 (de) 2009-04-23
WO2006058724A1 (en) 2006-06-08
IL183142A0 (en) 2007-09-20
AR051686A1 (es) 2007-01-31
PE20061078A1 (es) 2006-11-10
ATE425167T1 (de) 2009-03-15
RU2007124326A (ru) 2009-01-10
CN101068816A (zh) 2007-11-07
KR20070086869A (ko) 2007-08-27
NO20073283L (no) 2007-06-27
TW200635932A (en) 2006-10-16
MX2007006173A (es) 2007-07-09
CA2588741A1 (en) 2006-06-08
HK1101638A1 (en) 2007-10-18
JP2008521855A (ja) 2008-06-26
ES2259891B1 (es) 2007-11-01
EP1819710A1 (en) 2007-08-22
AU2005311423A1 (en) 2006-06-08
EP1819710B1 (en) 2009-03-11
ES2259891A1 (es) 2006-10-16
BRPI0518094A (pt) 2008-10-28
US20090029955A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
DE602005025924D1 (en) Royl-coa-desaturase
EP1769743A4 (en) RADIOTOMOGRAPHE
DE602005020252D1 (en) Röhrenförmige prothese
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
DE602004014986D1 (en) Terminal-box
EG23651A (en) Culturama
DE602005007474D1 (en) Substituierte morpholin- und thiomorpholinderivate
DE602005010905D1 (en) Roboterhandvorrichtung
DE602005011286D1 (en) Pyrazolopyridinderivate
ZA200703827B (en) New pyridothlenopyrimidine derivates
DE502005007040D1 (en) Laryngoskop
DE502005007456D1 (en) Nanoemulsionen
GB0421908D0 (en) New uses
EP1732560A4 (en) SUBSTITUTED CINNOLINE-4-YLAMINE
DE602005008719D1 (en) Notinformationsschild
IL180888A0 (en) Substituted n-acyl-2-aminothiazoles
DE602005026795D1 (en) Polythiourethan
DE502004004685D1 (en) Giessmaschine
DE602005010119D1 (en) Roboterhandvorrichtung
DE602005010440D1 (en) Lymerdispersionen
DE502005009795D1 (en) Modulares gelenkprothesensystem
EP1833808A4 (en) NEW BENZOTHIAZOLSULFONIC ACID AMIDE
DE602005025096D1 (en) Rotationsdämpfer
DE602005003029D1 (en) Polyaminoamidmonoepoxyaddukte
GB0417702D0 (en) New uses